An mHealth Strategy to Improve Medication Adherence in Adolescents With Sickle Cell Disease

About the study

The primary objective of this study is to evaluate a potential behavioral intervention
(MED-Go app). To meet this objective, the researchers will conduct a pilot randomized
controlled trial to test the feasibility and acceptability of MED-Go app in adolescents and
young adults (AYA) with sickle cell disease (SCD). The long-term goal of this research is to
promote medication adherence behavior and improve health outcomes in AYA with SCD.

Study point of contact

Kathryn King, BS
(312) 227-4825
katking@luriechildrens.org
Sherif M Badawy, MD, MS
(312) 227-4836
sbadawy@luriechildrens.org

Locations

1 United States site

Age

12 to 21 Years

Phase

N/A

Study type

Interventional

Gender

All

Interventions

Behavioral

Compensation

Unknown

participation requirements

– Age 12-21 years old

– Any sickle cell disease genotype

– On steady state of hydroxyurea for 2 months

– Own of have access to a smartphone during the study period

participation restrictions

– Recent hospitalizations within the past 7 days

Locations

  • Chicago, Illinois, United States, Ann & Robert H Lurie Children's Hospital of Chicago, 60611 [Recruiting]
Last updated 2021-02-16